Fluorescent Nanoparticles Enable Precise Tumor Imaging and Therapy

Fluorescent Nanoparticles Enable Precise Tumor Imaging and Therapy

Author: Aggregate

Bo Zhang, Southern University of Science and Technology, China, and colleagues have developed a new aggregation-induced emission (AIE) molecule named BPT. By integrating strong electron-donating phenothiazine units into a tetraphenylethylene core and coupling it with a benzobisthiadiazole (BBTD) acceptor, the resulting BPT nanoparticles exhibit NIR-II fluorescence emission at 1083 nm (quantum yield: 1.53%), 63% photothermal conversion efficiency, photoacoustic imaging capability, and generation of type I reactive oxygen species (O₂⁻).

The team further co-encapsulated BPT with the nitric oxide (NO) donor O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl) piperazin-1-yl]diazen-1-ium-1,2-diolate (JSK) into 1,2-distearoyl-sn-glycero-3-phospho-ethanolamine-methoxy poly-ethylene glycol2000 (DSPE-PEG2000) nanoparticles. These JSK-BPT nanoparticles (NPs) produce O₂⁻, NO, and ONOO⁻ upon irradiation, enhancing phototoxic effects. In vitro, JSK-BPT NPs eradicated most tumor cells at low concentrations under 808 nm laser exposure. In a 4T1 breast tumor mouse model, BPT NPs enabled high-resolution multimodal imaging of vasculature and tumor sites. Under the multimodal imaging guidance, a single dose of JSK-BPT NPs combined with laser irradiation led to complete tumor ablation.

This work extends the NIR-II emission capabilities of AIE materials and demonstrates a multifunctional platform for integrated imaging and phototherapy, addressing key challenges in tumor precision treatment and microenvironmental targeting.


 

 

Leave a Reply

Kindly review our community guidelines before leaving a comment.

Your email address will not be published. Required fields are marked *